A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies

Clinical trial NCT00923520 · COMPLETED

Trial details

NCT number: NCT00923520
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Renal Cell Carcinoma Breast Cancer Colon Cancer Lung Cancer Non-Hodgkin Lymphoma

Start date: 2009-03-25
Primary completion: 2016-05-12
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.